FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

8 results

amphetamine sulfate
(Amphetamine Sulfate)
Granules Pharmaceuticals Inc.
Usage: Amphetamine sulfate tablets are indicated for narcolepsy, Attention Deficit Disorder with Hyperactivity in conjunction with a comprehensive treatment program, and as a short-term adjunct for exogenous obesity in patients not responding to other weight loss strategies.
amphetamine sulfate
(amphetamine sulfate)
Lannett Company, Inc.
Usage: Amphetamine sulfate tablets (5 mg and 10 mg) are indicated for narcolepsy, Attention Deficit-Disorder with Hyperactivity as part of a comprehensive treatment program, and short-term management of exogenous obesity as an adjunct to a caloric restriction regimen in patients unresponsive to other therapies.
contrave
(naltrexone hydrochloride and bupropion hydrochloride)
Nalpropion Pharmaceuticals LLC
Usage: CONTRAVE is indicated for chronic weight management in adults with a BMI of 30 kg/m² or greater (obese) or 27 kg/m² or greater (overweight) with weight-related comorbid conditions, as an adjunct to diet and exercise. Safety with other weight loss products is not established.
diethylpropion hydrochloride
(Diethylpropion Hydrochloride)
Lannett Company, Inc.
Usage: Diethylpropion hydrochloride extended-release tablets, 75 mg, are indicated for short-term management of exogenous obesity in patients with a BMI of 30 kg/m² or higher who have not responded to diet and exercise alone. It is intended for use as monotherapy.
lomaira
(Phentermine Hydrochloride)
KVK-Tech Inc
Usage: LOMAIRA™ tablets are indicated for short-term weight reduction as an adjunct to exercise, behavioral modification, and caloric restriction in patients with a body mass index (BMI) of ≥30 kg/m², or ≥27 kg/m² with risk factors like controlled hypertension, diabetes, or hyperlipidemia.
phentermine hydrochloride
(phentermine hydrochloride)
SUNRISE PHARMACEUTICAL, INC.
Usage: Phentermine hydrochloride capsules are indicated as a short-term adjunct to weight reduction programs, including exercise, behavioral modification, and caloric restriction, for patients with exogenous obesity (BMI ≥ 30 kg/m² or ≥ 27 kg/m² with risk factors like hypertension, diabetes, or hyperlipidemia).
saxenda
(liraglutide)
Novo Nordisk
Usage: SAXENDA is indicated for weight management in adults and patients aged 12 and older with obesity (≥60 kg) or with overweight plus a weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity. Coadministration with other liraglutide-containing products is not recommended.
xenical
(orlistat)
H2-Pharma LLC
Usage: XENICAL is indicated for managing obesity through weight loss and maintenance, alongside a reduced-calorie diet. It also helps prevent weight regain post-weight loss and is suitable for obese patients with a BMI ≥30 kg/m² or ≥27 kg/m² with additional risk factors like hypertension, diabetes, or dyslipidemia.

Medications for Obesity

amphetamine sulfate

amphetamine sulfate

contrave

diethylpropion hydrochloride

lomaira

phentermine hydrochloride

saxenda

xenical